GSK plc (GSK)
GSK's Blenrep receives FDA approval, but faces scrutiny over label restrictions. The company is also involved in significant licensing deals within the China biotech sector.
About GSK plc
GSK plc is a multinational pharmaceutical and biotechnology company.
GSK plc uses the ticker $GSK for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- GSK plc (GSK) social dominance is up 143.18% from the previous [--] months.
Price: $58.90
Price 24-Hour Time-Series Raw Data
The stock price is near a 52-week high, supported by positive news like the FDA approval of Blenrep and recent acquisitions. However, potential volatility exists due to Blenrep's label restrictions, which are a significant critical theme in social discussions.
24-Hour: 0.1% 7-Day: 0.05% 30-Day: 22.21%
1-Year High: $60.20 on 2026-02-06
1-Year Low: $33.60 on 2025-04-10
AltRank: [---]
AltRank 24-Hour Time-Series Raw Data
GSK plc (GSK) is currently AltRank #812 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [---] [----]
[--] Month: [---] +575
[--] Months: [---] +392
[--] Year: [---] +263
1-Year High: [-----] on 2026-01-31
1-Year Low: [--] on 2025-06-08
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] +9
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-05-13
1-Year Low: [--] on 2025-07-03
Engagements: [-----] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Week: [-------] -58%
[--] Month: [-------] +156%
[--] Months: [---------] +2.40%
[--] Year: [---------] -1.30%
1-Year High: [-------] on 2025-07-30
1-Year Low: [---] on 2025-12-07
Engagements by network (24h): X: [-----] YouTube: [--] Reddit: [--]
Mentions: [---] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] -13%
[--] Month: [---] +57%
[--] Months: [-----] -28%
[--] Year: [-----] +55%
1-Year High: [---] on 2025-08-03
1-Year Low: [--] on 2025-12-07
Mentions by network (24h): X: [---] YouTube: [--] Reddit: [--]
Creators: [---] (24h)
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning GSK plc (GSK) in the last [--] hours which is down 12% from [---] in the previous [--] hours
Daily Average: [--]
[--] Week: [---] -9.60%
[--] Month: [---] +73%
[--] Months: [-----] -17%
[--] Year: [-----] +57%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-12-07
The most influential creators that mention GSK plc in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BioStocks | [--] | [------] | [--] | [-----] |
| @doepke_michel | [--] | [-----] | [--] | [---] |
| @ChartMill | [--] | [------] | [--] | [--] |
| @2kse8emv9xIk1J9 | [--] | [-----] | [--] | [--] |
| @Yam_Trades | [--] | [-----] | [--] | [--] |
| @SamFazeli8 | [--] | [-----] | [--] | [--] |
| @GSK | [--] | [-------] | [--] | [--] |
| @fwpharma | [--] | [------] | [--] | [--] |
| @kinatsofrim | [--] | [---] | [--] | [--] |
| @RedChip | [--] | [-----] | [--] | [--] |
Sentiment: 77%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 77%
Daily Average: 73%
[--] Week: 50% -32%
[--] Month: 50% -23%
[--] Months: 50% -9%
[--] Year: 50% -26%
1-Year High: 100% on 2025-03-21
1-Year Low: 37% on 2025-12-02
Most Supportive Themes:
- FDA Approval of Blenrep: (30%) GSK's multiple myeloma drug Blenrep has received FDA approval for specific patient groups, marking a significant regulatory milestone.
- Partnerships and Acquisitions: (20%) GSK is actively engaging in strategic partnerships and acquisitions, such as the deal with Empirico, to expand its pipeline and market reach.
Most Critical Themes:
- Blenrep Label Restrictions: (40%) Despite FDA approval, Blenrep's label is narrower than anticipated, raising concerns about its near-term commercial upside and market penetration.
- Pipeline Development Challenges: (35%) GSK faces ongoing challenges in its R&D pipeline, with some drug candidates like the one partnered with Alector failing in late-stage trials.
Social Dominance: 0.011%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.011%
Daily Average: 0.02%
[--] Week: 0.014% +0.0022%
[--] Month: 0.021% +0.0053%
[--] Months: 0.021% +0.0058%
[--] Year: 0.021% +0.0061%
1-Year High: 0.067% on 2025-08-03
1-Year Low: 0.0024% on 2025-12-07
Market Dominance: 0.134%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.134%
Daily Average: 0%
1-Year High: 2.90% on 2025-03-31
1-Year Low: 0.095% on 2025-07-21
Market Cap: $118,251,422,371
Market Cap 24-Hour Time-Series Raw Data
Current Value: $118,251,422,371
Daily Average: $85,744,885,104
[--] Week: $119,074,145,656 +0.75%
[--] Month: $118,251,422,371 +22%
[--] Months: $118,251,422,371 +47%
[--] Year: $118,251,422,371 +60%
1-Year High: $120,860,057,176 on 2026-02-06
1-Year Low: $68,072,746,997 on 2025-04-10
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing